HIV – 40 Years And Counting…

Activity Overview

With eight categories of HIV meds now available, healthcare professionals need to be up to date about these therapies. Whether using regimens from 20 years ago, or the newest drugs healthcare professionals need to be monitoring adherence to those regimens. By providing data from the San Francisco Study to show the need for 95% adherence. This Florida-approved course will also describe the advantages and disadvantages of each category of drugs, as well as those individual drugs. 

Learning Objectives

At the conclusion of this continuing education activity, the participant will be able to:

1. Define HIV and AIDS, its history, and epidemiology
2. Identify common modes of HIV transmission
3. Describe methods in which HIV may be transmitted in a healthcare setting
4. Discuss universal precautions and other infection control techniques that can reduce the risk of HIV transmission in healthcare settings
5. Identify common secondary infections and conditions associated with HIV and AIDS
6. Determine clinical strategies for the prevention and management of HIV and AIDS and describe the changes in HIV disease state management over the past 40 years
7. Discuss federal and Florida laws pertaining to HIV and AIDS, including confidentiality of testing, the treatment of patients, partner notification and reporting requirements, and the offering of HIV testing to pregnant women.

Course Details

Credits: 1 Contact Hour

________________________________

Delivery Type: Home Study Webcast

________________________________

Category: AIDS Therapy / Infection Control

________________________________

Target Audience:

Athletic Trainer

Clinical Lab Personnel

Dental Professional

Nurse

Certified Nursing Assistant

Speech-Language Pathologist

Audiologist

Pharmacist

Pharmacy Technician

Massage Therapist

Nursing Home Administrator

Occupational Therapist

Occupational Therapy Assistant

Podiatric Physician

Respiratory Care Practitioner

Respiratory Therapist

Licensed Midwife

Physicist

Physician

________________________________

Activity Type: Knowledge-based

________________________________

Accreditation Numbers:

ACCME Activity Number

202030158

________________________________

Universal Activity Number

Pharmacist:

0657-0000-21-163-H02-P

Pharmacist Technician:

0657-0000-21-163-H02-T

________________________________

AGD Provider ID# 386503

________________________________________

GNA Approved Provider Number is 4003268

________________________________________

Florida Board of Pharmacy: Provider no. 50-20641

_______________________________________

CE Broker No. 20-869919

________________________________

Activity Release Date: December 3, 2021

Activity Expiry Date: December 3, 2024 

________________________________

Accreditations 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Continuing Education Company, Inc. and AchieveCE. Continuing Education Company, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

Continuing Education Company, Inc. designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-869919.

AchieveCE is an approved provider of nursing continuing professional development by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. GNA Approved Provider Number is 4003268.

 AchieveCE is also an accredited provider by the Academy of General Dentistry (AGD) with provider ID #386503.

AchieveCE is also an approved provider by various state boards. 

Faculty Information

Peter A. Kreckel, RPh is a most unique breed of community pharmacist. He currently serves as the Director of Clinical Services at Nickman’s Drug Store, a five-store chain in southwestern Pennsylvania. Pete has also been recognized as the Pennsylvania Pharmacist Preceptor of the Year in both 2012 and 2019. He also received the National Community Pharmacy Association’s Preceptor of the Year Award in 2014. In 2015, he was honored by his alma mater with the University of Pittsburgh School of Pharmacy’s Distinguished Alumnus Award. He has precepted 65 students from the area’s schools of pharmacy.

Financial Support Disclosure

This activity was developed by AchieveCE free of any commercial support. Pete Kreckel, RPh, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose. Jaimini Patel, RPh, planner for this educational event, also have no relevant financial relationship(s) with ineligible companies to disclose. 

Should you be interested in taking this course offline, you may download this Activity Handout by clicking this link. Please return to this course page to take the Assessment Questions required for credit. A passing grade of 70 or higher and completion of an online activity evaluation are required to earn credit. Please click on the Complete and Continue buttons at the bottom of every page to track your progress.

Course Outline:

1. Knowledge Check
2. HIV: 40 years and counting...
3. About the Faculty
4. Learning Objectives
5. 1981
6. 1984
7. Modes of Transmission of HIV
8. New HIV Diagnoses Among the Most-Affected Populations in the US and Dependent Areas
9. Monitoring Antiretroviral Therapy (ART)
10. Frequency of Measurements
11. When To Start HIV Therapy?
12. Why Start So Soon?
13. AIDS-Defining Illnesses
14. Getting Patients On Board with Therapy
15. Life Cycle
16. 1987: The First “Nuke” Approved
17. Nucleoside Reverse Transcriptase Inhibitors
18. 1995: Protease Inhibitors Introduced
19. Protease Inhibitors
20. 1996: Non-Nucleoside Reverse Transcriptase Inhibitors Enters
21. Non-Nukes: Watch for Cross Over Resistance
22. New Mechanisms of Action Lead to Drop in Death Rates
23. 2003: Attachment Inhibitor Introduced
24. 2007: Chemokine Receptor Antagonist Introduced
25. 2007: Integrase Strand Inhibitors – A Game-Changer!
26. INSTI are first line, now
27. Most INSTI Come as Combo Products
28. 2018: Every disease needs a monoclonal antibody!
29. 2020: Gp120-Directed Attachment Inhibitor
30. 2021: Cabotegravir/rilpivirine (Cabenuva)
31. Cabotegravir/rilpivirine (Cabenuva) Dosing
32. Why PrEP?
33. More on PrEP
34. PEP for Exposed Health Care Workers
35. Healthcare Worker to Patient Transmission
36. Especially for Pharmacy Technicians!
37. It Isn’t Just About The HIV Drugs
38. Other Vaccines? Depends on CD4 count
39. Pregnancy and HIV
40. Treatment for Pregnant Patients
41. Treatment for the Neonate
42. Standard Precautions
43. Types of PPE in Healthcare Settings
44. Key Points About PPE
45. Florida — Here’s What Needs Covered.
46. Florida — It’s the LAW
47. References
48. Post-test
49. Course Evaluation